Low serum sodium as a poor prognostic indicator for mortality in congestive heart failure patients

Clinical Cardiology

Volumn 33, Issue 12, 2010, Pages

  Dewolfe, Andrew ^a   Lopez, Barbara ^a   Arcement, Lee M ^b   Hebert, Kathy ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Chabert Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SODIUM BLOOD LEVEL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AFRICAN AMERICANS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HUMANS; HYPONATREMIA; KAPLAN-MEIER ESTIMATE; LOUISIANA; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SODIUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650665656     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20560     Document Type: Article

References (13)

1. American Heart Association. Heart Disease and Stroke Statisticsâ 2008 Update. Dallas, Texas: American Heart Association; 2008. © 2008, American Heart Association.
2. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D., Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.
3. Levy D, Kenchaiah S, Larson MG, et al., Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347 (18): 1397-1402. (Pubitemid 35239711)
4. Kannel, WB., Incidence and epidemiology of heart failure. Heart Failure Review 2000; 5 (2): 167-173.
5. Lee WH, Packer M., Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986; 73 (2): 257-267.
6. Kearney MT, Fox KA, Lee AJ, et al., Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002; 40: 1801-1808.
7. Klein L, O'Connor CM, Leimberger JD, et al., Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study. Circulation 2005; 111: 2454-2460.
8. Gheorghiade M, Rossi JS, Cotts W, et al., Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Arch Intern Med 2007; 167 (18): 1998-2005.
9. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM., Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplantation. Circulation 1997; 95: 2660-2667.
10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325 (5): 293-302.
11. Foody JM, Farrell MH, Krumholz HM., β -Blockers in heart failure: scientific review. JAMA 2002; 287: 883-889.
12. Hunt SA, Abraham WT, Chin MH, et al., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). American College of Cardiology Website. Available at: J Am Coll Cardiol 2005; 46: e1-82.
13. Kearney MT, Nolan J, Lee AJ, et al., A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilized on angiotensin converting enzyme inhibitors. Eur J Heart Fail 2003; 5: 489-497.